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S-adenosylmethionine (SAM) and S-adenosylho-
mocysteine (SAH) link one-carbon metabolism to
methylation status. However, it is unknown whether
regulation of SAM and SAH by nutrient availability
can be directly sensed to alter the kinetics of key his-
tone methylation marks. We provide evidence that
the status of methionine metabolism is sufficient to
determine levels of histone methylation by modu-
lating SAM and SAH. This dynamic interaction led
to rapid changes in H3K4me3, altered gene tran-
scription, provided feedback regulation to one-car-
bon metabolism, and could be fully recovered upon
restoration of methionine. Modulation of methionine
in diet led to changes in metabolism and histone
methylation in the liver. In humans, methionine vari-
ability in fasting serum was commensurate with con-
centrations needed for these dynamics and could
be partly explained by diet. Together these findings
demonstrate that flux through methionine meta-
bolism and the sensing of methionine availability
may allow direct communication to the chromatin
state in cells.
INTRODUCTION
Alterations in the methylation status of proteins, nucleic acids,
and metabolites contribute to the pathogenesis of many of the
major human pathophysiological conditions including cancer,
obesity, and aging (Bergman and Cedar, 2013; Greer and Shi,
2012; Kraus et al., 2014). When these changes affect the methyl-
ation of histones and nucleic acids that determine the epigenetic
status in cells, they can affect the expression of thousands ofCell Mgenes (Barth and Imhof, 2010). Changes in methylation status
occur because of differences in the enzyme activity of methyl-
transferases and demethylases. Genes that encode these en-
zymes are frequently altered in pathological states, leading
to alterations in methylation (Chi et al., 2010; Dawson and
Kouzarides, 2012). It has also been long established that S-ad-
enosylmethionine (SAM) is the universal methyl donor for these
enzymes that transfer its methyl group to yield S-adenosylhomo-
cysteine (SAH) and a methylated substrate (Finkelstein, 1990).
The methylation of this substrate provides a link between the
metabolism that regulates SAMand SAH, whichmay act through
product inhibition of amethyltransferase, and the epigenetic sta-
tus of cells (Gut and Verdin, 2013; Katada et al., 2012; Teperino
et al., 2010).
SAM and SAH are intermediate metabolites in a metabolic
pathway that is a subset of a larger network collectively referred
to as one-carbon metabolism (Locasale, 2013). One-carbon
metabolism integrates nutrients from diverse sources such as
glucose, serine, threonine, methionine, and choline and pro-
cesses them into distinct outputs that achieve diverse biological
functions. Whether the concentrations of SAM and SAH or their
ratio ever reach values that could affect methyltransferase activ-
ity has been controversial. Some studies have concluded that
their concentrations do not reach limiting values (Hoffman
et al., 1979). Recent studies, however, have provided evidence
that aberrant expression of NNMT, an enzyme that metabolizes
SAM, has profound biological consequences resulting from
changes in histone methylation (Kraus et al., 2014; Ulanovskaya
et al., 2013). Others have found that only the levels of SAH corre-
lated with methylation status (Caudill et al., 2001), including a
recent finding that investigated threonine metabolism in mouse
pluripotent stem cells and demonstrated that threonine catabo-
lism affected both pyruvate and glycine metabolism and altered
histone methylation (Shyh-Chang et al., 2013). Although this
study was the first to our knowledge to document the influence
of an amino acid on histone methylation, this effect was shown
to occur through indirect pathways involving energy productionetabolism 22, 861–873, November 3, 2015 ª2015 Elsevier Inc. 861
and acetyl-coA metabolism. Further studies have demonstrated
in human pluripotent stem cells that a depletion of methionine,
the precursor to SAM, could lead to changes in histone methyl-
ation (Shiraki et al., 2014). However, these changes are also
accompanied by widespread induction of stress response path-
ways and cell death, confounding the interpretation of whether
the changes in histonemethylation occurred through the sensing
of SAM/SAH status.
Given these previous findings, we hypothesized that there ex-
ists a direct mechanismwhereby the status of one-carbonmeta-
bolism could alter the concentrations of SAM and SAH to confer,
through their interaction with methyltransferases, the output of a
defined methylation state. We focused on histones because key
methylation modifications on their tails, such as trimethylation at
lysine 4, are known to be required for themaintenance of defined
cellular states (Benayoun et al., 2014; Ruthenburg et al., 2007)
and have been shown to be modulated by metabolism (Shiraki
et al., 2014; Shyh-Chang et al., 2013). We provide evidence in
cells and mice that both SAM levels and the SAM/SAH ratio
can be quantitatively tuned through changes in the metabolic
flux of the methionine cycle to affect a critical component of
chromatin status. This regulation occurred at physiologically
relevant concentrations and appeared to control numerous
physiological processes, including direct feedback regulation
for the maintenance of homeostasis in one-carbon metabolism
and the activity of genes involved in cancer and cell fate.
Together these findings are consistent with a model whereby
the status of one-carbon metabolism is in communication with
the chromatin state of cells through its ability to modify the
kinetics of enzymes that mediate histone methylation.
RESULTS
Methionine Metabolism Quantitatively Affects Histone
Methylation
Because methionine is the closest substrate in the methionine
cycle and the one-carbon metabolic cycle that affects SAM
levels, we tested whether cells depleted of methionine have al-
terations in the methionine cycle and whether this would confer
effects on the methylation of histones. We generated a media
formulation in which methionine was restricted from the culture
media. HCT116 cells were placed in this methionine-restricted
(MR) (3 mM) media for 24 hr. We then used a liquid chromatog-
raphy, high-resolution mass spectrometry (LC-HRMS) metabo-
lomics technology we have recently developed (Liu et al.,
2014b) to generate a quantitative profile ofmore than 300metab-
olites in response to methionine restriction that is visualized in a
volcano plot (Figure 1A). It was found that metabolites in the
methionine cycle exhibited dramatic changes in their concentra-
tions, with only moderate compensation from other pathways
that fuel the one carbon cycle (Figure 1B). Notably, both SAM
and SAH are depleted under these conditions. To test whether
these alterations were sufficient to induce changes in histone
methylation, we considered the relative levels of several histone
methylation marks involving trimethylation at lysines 4, 9, and 27
that are each known to have substantial roles defining chromatin
states, most notably at active and inactive genes, and mediating
gene expression (Shilatifard, 2006) (Figure 1C). In addition, the
kinetic properties, such as SAMbinding affinity (Km), of these his-862 Cell Metabolism 22, 861–873, November 3, 2015 ª2015 Elseviertone methyltransferases (An et al., 2011; Chin et al., 2005; Hori-
uchi et al., 2013; Obianyo et al., 2008; Patnaik et al., 2004; Xiao
et al., 2003) suggest that SAM concentration may play a role in
their regulation and directly affect the rate of histone methylation
reactions in the cell (Figure S1A). Each modification exhibited
decreased methylation, with trimethylation at lysine 4 on histone
H3 (H3K4me3) exhibiting the largest change. To investigate
whether these changes were specific to methionine restriction,
we considered the removal of several other amino acids (W, Q,
K, H, and L) that include essential amino acids and glutamine,
which has been shown to be essential for cell proliferation (Fig-
ure 1D). We found that in each case no change in histonemethyl-
ation was observed. To further test the generality of this observa-
tion, we considered the response of H3K4me3 to methionine
restriction on a panel of six human cell lines subjected to methi-
onine restriction for 24 hr. In each case, H3K4me3 was respon-
sive to methionine restriction (Figure 1E). Additionally, we
observed decreases in H3K9ac after methionine restriction (Fig-
ure S1B). Having shown that extreme restriction of methionine
is sufficient to alter histone methylation, we investigated the
concentration of methionine needed to achieve this effect. We
considered a titration of differing concentrations of methionine
in the culture media ranging from 3–500 mM. The relative levels
of the methionine cycle and one-carbon metabolism-related
metabolites, including methionine, SAM, SAH, homocysteine,
betaine, and dimethylglycine (DMG), were measured (Figure 1F).
It was found that the levels of these intermediates exhibited a
graded response to changes in methionine concentration in
the media. SAM and SAH were altered at concentrations below
25 mM, concentrations well below those present in typical culture
media. We next investigated the dose response of changes in
histone methylation to changes in methionine availability (Fig-
ure 1G). Histone methylation responded differently to differing
concentrations of methionine. H3K4me3 was affected at con-
centrations between 10 and 25 mM, consistent with concentra-
tions needed to deplete SAM and SAH in the methionine cycle.
One possibility is that these changes were due to non-specific
effects on cell proliferation. We therefore considered the effects
of methionine restriction on cell proliferation over a course of
3 days (Figures 1H and S1C). At low concentrations of methio-
nine, there were marked defects in cell morphology and cell pro-
liferation but no activation of p53 when H3K4me3 was changing
(Figures S1C and S1D), indicating that H3K4me3 dynamics
occur before a cellular stress response. At 10 mM, cells remained
viable, with no gross alterations in morphology and only a
modest decrease in cell proliferation that was fully recoverable
at 25 mM, confirming that the changes in histone methylation
are not likely due to defects in cell proliferation. Together these
findings demonstrate that methionine affects histone methyl-
ation and the dynamics of the methionine cycle.
Methionine Cycle and Histone Methylation Dynamics in
Response to Methionine Restriction
Having observed alterations in the methionine cycle and
concomitant changes in histone methylation, we sought to un-
derstand the dynamics of the process and its connection to
cellular metabolism.We reasoned that the kinetics could provide
further insights into how changes in metabolism alter histone
methylation.Inc.
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Figure 1. Methionine Metabolism Alters Histone Methylation Status
(A) Metabolomics profile of MR HCT116 cells. Log2 fold change versus log10 (p value) (Student’s t test, two-tailed, n = 3).
(B) Effects of methionine restriction on one-carbon cycle metabolism.
(C) Effects of methionine restriction on histone methylation measured by immunoblotting. Band intensities are normalized to total H3 levels, and relative intensity
was calculated compared with control cells.
(D) Effects of deprivation of other amino acids on histone methylation. Data are normalized to control media.
(E) Effects of methionine restriction on histone methylation across a panel of cell lines.
(F) Relative concentration of methionine cycle metabolites in cells cultured in different concentrations of methionine.
(G) Concentration-dependent effects of methionine restriction on histone methylation. Data are normalized to the 100 mm condition.
(H) Cell proliferation of HCT116 cells for differing levels of methionine.
All error bars are computed from SEM (n = 3), all quantitation is normalized to the total H3, and the fold change between experimental and control groups are
reported.We considered the metabolic dynamics of methionine restric-
tion across 12 time points (0, 5, 15, 30, 60, 90, 120, 240, 360, 540,
720, and 1,440 min), from very early time up to times leading to
cell death (Figure 2A). At each of these time points, we profiled
more than 300 metabolites spanning pathways across central
carbon and secondary metabolism. A hierarchical clustering of
the time course revealed coordinated dynamics across the
metabolome in response to methionine restriction. Waves of
coordinated changes that involve different metabolic pathways
were observed. We used a recently developed algorithm for as-
sessing the contribution to different pathways (i.e., pathway
impact) defined by the Kyoto Encyclopedia of Genes and
Genomes (Xia and Wishart, 2010) (Figure 2B). Pathway impact
is computed by considering a weighted score of each metabo-
lite, with greater weights being assigned to metabolites that
are centrally located in a given metabolic pathway. At early
times, a module related to cysteine and methionine metabolismCell Mexhibited decreasing dynamics that were sustained across the
time course. At intermediate times, alterations in metabolites
belonging to phenylalanine, tryptophan, and lysine metabolism
were observed. At later times, arginine and proline metabolism
appeared altered together, suggesting that a complex compen-
satory amino acid response at later times occurs after the pri-
mary response to methionine restriction. Interestingly, pathways
such as glycolysis, the tricarboxylic acid cycle, and anabolic
metabolism associated with nucleotide and lipid metabolism ap-
peared not to exhibit coordinated dynamics, suggesting that
general effects on metabolism and cell proliferation do not
appear altered throughout the kinetics. A further inspection
of the module related to methionine cycle dynamics revealed
that within minutes of methionine restriction, methionine was
depleted within cells (Figure 2C). SAM levels exhibited a decay
that occurred within 1 hr (Figure 2D). SAH levels exhibited
more complex behavior involving a fast decrease, a recoveryetabolism 22, 861–873, November 3, 2015 ª2015 Elsevier Inc. 863
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Figure 2. Histone Methylation Is Dynamically Regulated by Methionine Metabolism
(A) Global metabolic dynamics in response to methionine restriction.
(B) Pathway analysis of dynamics shown in (A).
(C) Dynamics of methionine.
(D) Dynamics of SAM.
(E) Dynamics of SAH.
(F) Dynamics of the SAM/SAH ratio.
(G) Dynamics of histone methylation.
(H) Quantitation of results in (G) and two other independent experiments.
Integrated intensities are normalized to total H3, and the fold change represents differences compared with 24 hr. All error bars are computed from SEM (n = 3).at 2 hr, and a later decrease (Figure 2E). These dynamics are
likely due to additional pathways, such as remethylation from
one-carbon metabolism, methionine salvage, and flux into the
transsulfuration pathway. These changes contributed to compli-
cated dynamics of the SAM/SAH ratio that decreased at 2 hr
(Figure 2F). In addition, 5-methyltetrahydrafolate did not
contribute to the methionine cycle, as measured by 13C serine,
indicating that the folate cycle is largely uncoupled to the methi-
onine cycle in these cells (Figure S2). We next monitored the
dynamics of histone methylation to assess its interaction with
metabolic dynamics. We considered the dynamics of the levels
of H3K4/9/27 in response to methionine restriction (Figures 2G
and 2H). Surprisingly, it was found that within 2–4 hr, a depletion
of histone methylation was observed. These kinetics exhibited
only a 1–2 hr lag between depletion of the methionine cycle
and the subsequent changes in histone methylation. These
dynamics are generally too short for a transcriptional or transla-
tional regulatory response. Together, these findings suggest that
the dynamics of methionine metabolism result primarily in amino864 Cell Metabolism 22, 861–873, November 3, 2015 ª2015 Elsevieracid compensatory responses and not general features that lead
to disruption of cell proliferation. They also indicate that methio-
nine dynamics can be coordinately sensed by histones to deter-
mine the levels of histone methylation.
Methionine Metabolism and Histone Methylation
Dynamics Are Reversible
Thus far we have shown that methionine metabolism can induce
alterations in histone methylation levels and that this effect is dy-
namic and occurs on timescales consistent with that of a direct
sensing mechanism. Another necessary requirement of such a
signal transduction mechanism is that the dynamics be revers-
ible. We therefore questioned whether metabolism and histone
methylation can be recovered after methionine restriction. Cells
were subjected tomethionine restriction for 24 hr (between day 1
and day 2), at which point we allowed the cells to be cultured for
an additional 24 hr in media containing the full concentration of
methionine (between day 2 and day 3) (Figure 3A). We carried
out metabolomics at each time point, as considered previouslyInc.
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Figure 3. Histone Methylation and Methionine Cycle Dynamics Are Reversible
(A) Experimental setup of methionine restriction and recovery.
(B) Effects of methionine restriction and recovery on global metabolism.
(C) Pathway analysis of methionine recovery.
(D) Effect of methionine restriction and recovery on methionine cycle metabolism.
(E) Effect of methionine restriction and recovery on the methionine salvage and transsulfuration pathways.
(F) Response of histone methylation from methionine restriction and recovery.
Integrated intensities are normalized to total H3, and fold change was calculated. All error bars are computed from the SEM (n = 3).(Figure 3B). Hierarchical clustering of each profile revealed
marked changes across the metabolic network at days 1, 2,
and 3. The gross measured differences in metabolism from
day 1 and day 3 revealed that overall metabolism is not reversible
under these conditions. An assessment of the pathways involved
indicated that several amino acidmetabolism pathwayswere not
recoverable at 3 days (Figure 3C). Of the pathways recovered af-
ter reincorporation of methionine into the culture media, cysteine
andmethioninemetabolismwas one of three pathways shown to
be reversible. This effect is illustrated in Figure 3D, in which the
methionine cycle is plotted, and for each metabolite in the cycle,
some recovery of its concentration and the concentration of the
metabolites in its salvage pathway (Figure 3E) was observed. To
investigate whether these dynamics correlated with histone
methylation, we measured histone methylation levels (Figure 3F)
and found thatmethylation levels exhibited a concomitant recov-
ery back to levels observed in the original culture conditions.
Together these findings indicate that the methionine cycle is
reversible even when the remainder of global metabolism isCell Maltered. Furthermore, these results show that the recovery of
the levels of metabolites in the methionine cycle is sufficient to
restore the levels of histone methylation.
Methionine Restriction Decreases H3K4me3 Signature
Peaks and Alters Gene Expression
Although results from immunoblotting identified global alterations
in histonemethylation aftermethionine restriction, it remainedun-
clear whether methionine metabolism affected specific marks on
the genome to mediate gene expression. We therefore sought to
determine the precise location H3K4me3 on the genome using
chromatin immunoprecipitation with sequencing (ChIP-seq) and
the consequences on gene expression using RNA sequencing
(RNA-seq). The specificity of the H3K4me3 antibody was first
confirmed with modified histone peptide array, and sensitivity
was tested using serial titrations of H3K4me3 peptides, as sug-
gested in the Encyclopedia of DNA Elements guidelines (Bailey
et al., 2013) (FiguresS4AandS4B).Cellswere subjected tomethi-
onine restriction (MET) or normal methionine (+MET) conditionsetabolism 22, 861–873, November 3, 2015 ª2015 Elsevier Inc. 865
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Figure 4. Methionine Restriction Decreases H3K4me3 and Alters Gene Expression
(A) Change in H3K4me3 distribution around the TSS after 24 hr methionine restriction.
(B) Genome-wide distribution of H3K4me3 peaks in +MET (red) and MET (blue) conditions.
(C) Enlargement of chromosome 17.
(D) Changes in H3K4me3 ChIP-seq signal with corresponding changes in gene expression from RNA-seq for colon cancer genes.
(E) Enzymes with decreased H3K4me3 and gene expression essential in one-carbon metabolism and related pathways are highlighted in red.
(F) H3K4me3 ChIP-seq and RNA-seq signals for enzymes in (E) before and after methionine restriction.for 24 hr, and crosslinked chromatin was collected for H3K4me3
ChIP-seq analysis, with total RNA collected for RNA-seq in
parallel. After peak calling (Experimental Procedures), replicate
samples for the +MET and MET conditions clustered together,
suggesting the genome-wide profile of H3K4me3 marks are
similar between replicates but vastly different between the condi-
tions (Figure S4C). Next, we investigated the change in H3K4me3
peaks at the transcription start site (TSS) of genes, because
H3K4me3at genepromotershasbeenassociatedwithgene tran-
scription. Overall, we found that the H3K4me3 peaks around the
TSS are bimodal and decrease, on average, after methionine re-
striction (Figure 4A). In addition, H3K4me3 peaks decreased in
breadth after methionine restriction (Figure S4D), but no signifi-
cant change in H3K4me3 binding site distribution around the
TSS was observed (Figure S4E).
Next, peak counts were plotted for each chromosome,
showing that H3K4me3 peak distribution across the genome
is relatively consistent (Figure 4B). Closer inspection of individual
chromosomes revealed that particular genomic regions are
differentially marked by H3K4me3 (Figure 4C), and further differ-
ential binding analysis indicated significantly depleted regions of
H3K4me3 (Figure S4F).866 Cell Metabolism 22, 861–873, November 3, 2015 ª2015 ElsevierBecause promoter H3K4me3 is a signature for active tran-
scription, we further investigated how decreased H3K4me3 at
promoters affects gene transcription. To this end, we performed
RNA-seq (Figure S4G) under MR conditions in HCT116 and
compared these results with our ChIP-seq analysis. Interest-
ingly, we found that colorectal cancer (CRC)-associated genes
were enriched for loss of H3K4me3 at promoters, with resulting
decreased expression (p = 0.02, Fisher’s exact test). Notably,
the cancer-associated genes AKT1, MYC, and MAPK, among
others, were responsive to decreases in promoter H3K4me3
(Figure 4D). In addition, CRC genes that had significant de-
creases in gene expression also showed significant decreases
in H3K4me3 over the promoter region when compared with
genome-wide loss of H3K4me3 (Figure S4H). Overall, these
results suggest that nutrient status has a dramatic effect on
the chromatin state and gene regulation in cells with likely effects
on pathophysiological outcomes.
To further evaluate specific physiological consequences of
this mechanism, we identified a network of enzymes involved
in one-carbon metabolism that show decreased H3K4me3
with concomitant decreases in expression (Figure 4E). This sug-
gests a feedback mechanism that decreases consumption ofInc.
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Figure 5. Alterations in Methionine Metabolism Can Be Sustained by Diet In Vivo
(A) Methionine restriction in mice with representative histology in MR and control mice. Images are at 403 with hematoxylin and eosin staining.
(B) Fold change of serum amino acids in MET compared with +MET, measured by LC-MS (*p < 0.001).
(C) Methionine cycle metabolites in liver of MR mice.
(D) Methionine cycle metabolites in plasma of MR mice.
(E) Histone methylation in liver of MR mice. Integrated intensities were normalized to total H3.
(F) Quantitation of results histone methylation from n = 8 mice in each cohort. p value was obtained from a Student’s t test with equal variance.
(G and H) Correlation of histone methylation and methionine cycle metabolites in liver and plasma.SAM by alternative pathways and an attempt to maintain
H3K4me3 by regulation of JARID1B (KDM5B), H3K4me3 deme-
thylase that is deregulated in cancer (Yamane et al., 2007). This
finding is indicative of a signal transduction mechanism by which
alterations in H3K4me3 directly feed back to one-carbon meta-
bolism and methylation-related enzymes to maintain physiolog-
ical homeostasis.
Methionine Cycle Alterations Can Be Sustained by Diet
In Vivo
We next questioned whether changes in methionine can occur
through and are maintained in response to alterations in nutrient
availability in a longer term physiological setting. We considered
an analysis of the effects of methionine restriction in vivo at a
concentration that has been shown to have health-promoting
effects (Ables et al., 2012). Seven-week-old C57Bl6 mice were
randomized into two groups, and one arm was fed a standardCell Mdiet consisting of 0.84% (w/w) methionine and the other a MR
diet consisting of more than seven times less methionine
(0.12%w/w) (Figure 5A). We first confirmed that theMRdiet spe-
cifically decreased serum methionine levels compared with the
levels of all other amino acids (Figure 5B). At 12 weeks, mice
were sacrificed, and no gross phenotypic alterations were
observed as measured by liver histology and as previously
described (Ables et al., 2012) (Figure 5A). An examination of
the metabolite profile in the fasting serum and liver by carrying
out unsupervised hierarchical clustering revealed global alter-
ations in metabolism in the liver and plasma (Figure S5A), with
a pathway analysis revealing that cysteine andmethionine meta-
bolism was predominantly altered in plasma (Figure S5B). Other
amino acid metabolism pathways to a lesser extent exhibited
alterations. Inspection of metabolism in the liver exhibited sus-
tained alterations in cysteine and methionine, along with alter-
ations in taurine metabolism and other amino acid metabolismetabolism 22, 861–873, November 3, 2015 ª2015 Elsevier Inc. 867
pathways (Figure S5C). Globally, an analysis of the quantile-
quantile plot showed skewness toward more changes observed
in the liver but with more significant changes occurring in the
serum (Figure S5D). These differences were further exemplified
by comparing correlations of metabolite levels between liver
and plasma (Figure S5E), with metabolites related to beta oxida-
tion such as acylcarnitines, amino acid metabolism, and one-
carbon metabolism found to correlate with the extent of
methionine levels in the plasma (Figure S5F).
Together these findings indicate that the regions of the meta-
bolic network that are altered in response to sustained methio-
nine restriction in vivo are comparable with those aspects of
the metabolic network that are dynamic in response to acute
methionine restriction in cells. Furthermore, the metabolic state
of fasting liver is dramatically different in the animals that were
maintained on different diets for the long term.
Methionine Restriction In Vivo Sustains Altered
Methionine Cycle and Histone Methylation
Having demonstrated that cysteine and methionine metabolism
exhibit sustainable alterations in mice, we then asked whether
these changes led to differences in the methionine cycle. In the
liver (Figure 5C), methionine concentrations exhibited no signifi-
cant changes, suggesting that compensatory fluxes involving its
consumption or intake are occurring. These changes in fluxes
resulted in decreases in SAM, SAH, the SAM/SAH ratio, cysta-
thionine, and methylthioadenosine and increases in the methyl
donors DMG and betaine. However, in plasma (Figure 5D),
methionine levels were maintained at lower levels. In addition,
cystathionine and 2-keto-4-methylthiobutyrate, a component
of the methionine salvage pathway, were also significantly
decreased. Conversely, betaine and DMG each exhibited in-
creases suggestive of their possibility as plasma biomarkers.
The methionine cycle metabolites SAM and SAH did not show
changes in plasma. This observation was expected because
cells are not thought to secrete these metabolites at appreciable
concentrations (Agrimi et al., 2004). We next asked whether
these sustained changes in the methionine cycle were sufficient
to induce changes in histone methylation. We observed de-
creases in H3K4me3 in theMR liver (Figure 5E) that we quantified
(Figure 5F), indicating that the alterations in SAM and SAH levels
observed in the liver are sufficient to induce global changes in
histone methylation. We found that SAM, the SAM/SAH ratio,
and cystathionine positively correlated with H3K4me3 levels,
and methionine, betaine, and DMG negatively correlated with
H3K4me3 levels (Figures 5G and S5G). In plasma, the levels of
methionine and cystathionine were positively correlated, and
betaine and DMG were negatively correlated (Figures 5H and
S5H). Together these findings provide evidence that levels of
SAM and SAM/SAH ratio are predictive of histone methylation
levels, that plasma metabolites in methionine cycle metabolism
are predictive of histone methylation in the liver, and that these
levels can be directly modulated by diet in mice.
Humans Exhibit Variability in Methionine Levels
We next questioned whether variability in methionine meta-
bolism exists in humans and how it can be regulated. Standard
clinical parameters and a record of dietary intake over 4 days
were considered to reflect variations in habitual diet, as is stan-868 Cell Metabolism 22, 861–873, November 3, 2015 ª2015 Elsevierdard practice in clinical nutrition (Levine et al., 2014) across a
cohort of healthy human subjects. Fasting serum was collected
and subjected to a metabolomics analysis (Figures 6A and S6A).
We performed an unsupervised hierarchical clustering of the
nutrient intake for each subject and found sets of defined mod-
ules that were able to classify the subjects into discrete dietary
behaviors, such as groups that were high in fruits and vegetables
or carbohydrates (Figure 6B). We next measured the concentra-
tion of methionine along with a panel of amino acids in these
subjects (Figure 6C). Strikingly, the concentration of methionine
exhibited substantial variation, with values ranging from 3–30 mM
and methionine exhibiting the largest variation (Figure 6D). This
variation in concentration is on the same order as that needed
to induce changes in histone methylation in cells and in mice.
In addition, methionine in the serum correlates with N,N,N-trime-
thyllysine and N-methylglycine (sarcosine), both of which are
methylated by the transfer of methyl groups from SAM, suggest-
ing that methionine levels in the serum are indicative of cellular
methylation status (Figure 6E), with clear patterns of food con-
sumption that corresponded to both high and low methionine
intake (Figures 6F and S6B). Vegetable-based nutrients such
as fiber correlated with low methionine levels, and age, body
weight, and fat intake correlated with high methionine levels.
Surprisingly, protein intake exhibited no correlation with methio-
nine. An analysis of the metabolites and pathways that corre-
lated with methionine levels (Figures 6G and S6C) revealed
pathways related to ketogenesis and amino metabolism. Taken
together, these findings demonstrate that the variability in
methionine concentration in humans is on the same scale as
that needed to induce alterations in histone methylation and
that these differences correlate with changes in diet and health
status.
A Computational Model Identifies Factors that
Contribute to Methionine Variability
Finally, having identified associations of methionine with diet and
other factors, we built a computational model to identify the
direct influences on methionine concentration. We considered
a mixed-effects model that aimed to identify causal features in
high-dimensional data and thus identify factors that give rise to
the variation in methionine levels (Figure 7A). We considered di-
etary intake variables and clinical variables such as age, gender,
and body composition measured by dual-energy X-ray absorp-
tiometry (DEXA). To reduce the dimensionality of the data matrix,
we filtered the variables according to their correlations with
methionine, carried out a principal-components analysis on the
DEXA variables (Figure S7A), and checked the resulting 12 vari-
ables for collinearity (Figure S7B). We then carried out a regres-
sion using least-squares minimization with maximum likelihood
estimation (Supplemental Information) and obtained a model
with good fit (p < 104, F test) to the experimental methionine
concentrations (Figure 7B).
An analysis of the coefficients (Figure 7C) revealed several con-
tributions to methionine variation, including age, body composi-
tion, gender (with maleness contributing to a positive influence),
and diet, including variables known to be associated with
methionine, including zinc and tocepherol. Using established
guidelines (Experimental Procedures), it was found that the diet
variables could be related to major sources of food intakeInc.
Figure 6. Methionine and Metabolic Variation in Human Subjects
(A) Measurement of serum methionine and clinical and dietary variables in human subjects.
(B) Left: Hierarchical clustering of the distance matrix diet variables. Right: k-Means clustering of subjects and diet variables (n = 24).
(C) Absolute concentrations of amino acids in fasting serum in 38 human subjects.
(D) Coefficients of variation of amino acids in fasting serum.
(E) Correlation of methionine in the serum with methylated serum metabolites, N,N,N- trimethyllysine, and sarcosine.
(F) Correlation of methionine concentrations with dietary variables obtained from habitual diet records.
(G) Pathways enriched with metabolites that correlate (jrj > 0.2) with serum methionine concentration.(Figure7D)with, for example, fats, seafood, andmeatcontributing
to higher concentrations of methionine. Finally, we performed a
variance partitioning calculation (Figure 7E) and found that about
30%of the variation was explained by diet, about 30%by clinical
variables including gender and age, and the remaining unac-
counted variance likely due to genetic factors. These results indi-
cate that methionine concentrations observed in humans can be
decomposed into several factors, including diet.
DISCUSSION
These findings together provide evidence for a dynamic regula-
tory mechanism whereby the status of the methionine compo-
nent of one-carbon metabolism is sensed by histones to deter-
mine the levels of methylation on critical residues that mediate
cellular epigenetic status. We first demonstrated that methionine
deprivation and subsequent depletion of SAM and SAH induceCell Mchanges in histone methylation. Furthermore, we tested and
confirmed that these dynamics occurred in a manner consistent
with a signal transduction mechanism. Necessarily, we found
that changes in histone methylation occurred at quantitatively
relevant concentrations of methionine. The kinetics of turnover
of histone methylation in response to SAM and SAH availability
were found to occur within hours and thus are much shorter
than times corresponding to changes in cell-cycle progression
or global stress responses that also affect histone methylation.
Importantly, these dynamics were found to be reversible, as
the depletion of histone methylation could be recovered upon
restoration of methionine availability even when the remainder
of cellular metabolism was not recovered. Each of these proper-
ties is consistent with a mechanism whereby the status of key
histone marks such as H3K4me3 that mediate chromatin struc-
ture, gene expression, and cell identity directly sense the meta-
bolic status of one-carbon metabolism.etabolism 22, 861–873, November 3, 2015 ª2015 Elsevier Inc. 869
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Figure 7. A Computational Model Identifies Determinants of Methionine Variability
(A) Overview of variable selection for the computational model.
(B) Predicted versus measured methionine levels in human subjects.
(C) Regression coefficients. Error bars are obtained from maximum likelihood estimates.
(D) Schematic of dietary factors that contribute to each modeled variable.
(E) Results from variance partitioning.In vivo, the dynamic response to methionine restriction further
provided support of such a mechanism, because alterations in
SAM and SAH could be sustained in liver, and these changes
were sufficient to induce changes in histonemethylation. Interest-
ingly, although this dietary intervention maintained reduced
methionine levels in the serum, the levels in the liver were not
altered. This suggested compensatory adaptations inmethionine
fluxes occurred, likely through other remethylation pathways, for
example, from folate metabolism. These metabolic adaptations
likely serve to maintain other essential processes involved in
methioninemetabolism, possibly providing a basis forwhymethi-
onine restriction can be sustained in healthy animals even when
changes in histone methylation are observed. Notably, methyl-
ationstatus andmetabolismweremeasured in fasting conditions,
inwhichmethionine restrictionwas shown to alter histonemethyl-
ation. This fasted condition, we expect, sets a lower bound on
the extent to which the methionine cycle can be depleted, with
feeding contributing to increases in methionine levels. Given
this observation, it is tempting to speculate that feeding or a
diurnal rhythmmight regulate this effect, perhaps raising methio-
nine levels to recover depletions in histone methylation.
In humans, the variation of methionine in healthy individuals
was found to be largest across a panel of serum amino acids.
Although these measurements are by no means exhaustive of870 Cell Metabolism 22, 861–873, November 3, 2015 ª2015 Elsevierhuman population dynamics, concentrations in many individuals
were found to be far lower than the concentration required to
induce changes in methylation levels. Computational modeling
of diet and clinical variables found that about 30% of the varia-
tion could be due to fundamental clinical variables such as
age, body composition, and gender, and about 30%was modu-
lated by diet. In the future, the results from these models could
further be integrated with genomics data to specifically define
the genetic contributions, as have been identified to associate
with serum metabolite levels (Suhre et al., 2011). Nevertheless,
it is tempting to speculate that basic dietary factors such as
vegetable and fat intake could mediate human epigenetics
through modulation of methionine metabolism.
One-Carbon Metabolism as a Metabolic Signal
Transduction Mechanism
Cellular decision making occurs through signal transduction
that uses post-translation modifications. For example, protein
kinases establish networks of protein phosphorylation with
multiple layers of nonlinear regulation that control almost all as-
pects of physiology. Despite the ubiquitous importance of his-
tone and other macromolecular methylation, relatively little is
known about howmethylation is regulated. In contrast to protein
kinases, whereby the substrate, ATP, is in vast excess, theInc.
concentrations of SAM and SAH are on the order of the kinetic
parameters that determine enzyme activity. Thus, much of his-
tone and other methylation could be regulated in large part by
the status of methionine metabolism and one-carbon cycle
flux, consistent with relatively small numbers of methyltrans-
ferases compared with the more than 500 protein kinases that
exist. This type of regulation by virtue of its biochemistry would
have fundamentally different control properties and information
capacity than that of protein kinase-mediated signaling. This
regulation is evident in the feedback control observed in genes
in one-carbon metabolism, whose expression and H3K4me3
signature is modulated in response to decreases in SAM
and SAH levels, likely as a specific mechanism to maintain ho-
meostasis in one-carbon metabolism. In particular, enzymes
important in regenerating methionine by using SAM are some
of the most downregulated genes with loss of H3K4me3 at their
promoters.
Methionine Metabolism in Pathophysiology through Its
Modulation of Chromatin State
Numerous studies have documented a contribution of methio-
ninemetabolism and its restriction to beneficial metabolic health,
including the extension of mammalian lifespan, the acquisition of
resistance to diet-induced obesity, and the therapeutic efficacy
of ketogenic diets (Kraus et al., 2014; Malloy et al., 2006; Oren-
treich et al., 1993; Pissios et al., 2013). In each of these cases,
the biological mechanisms contributing to these outcomes are
largely unknown. Although alterations in methylation status likely
do not account for all of these effects, it is possible if not likely
that the alterations in gene expression of key genes are impor-
tant for the relevant physiological effect in each of these cases.
Indeed, chronic diseases, including obesity, diabetes, and can-
cer, often stem from the inability of the organism to adapt to
the demands of its nutritional load (Hotamisligil, 2010; Laplante
and Sabatini, 2012). These adaptations require signal transduc-
tion mechanisms that integrate nutritional status to achieve the
desired physiological demand. There are numerous signal trans-
duction pathways that sense nutritional status, and it is likely
that the sensing of one-carbon metabolism by histones is one
of these mechanisms.
Interestingly, this mechanism affected gene regulation of
several cancer-promoting genes. Many cancers are vulnerable
to disruptions in one-carbon metabolism (Locasale, 2013), and
our results demonstrate the necessity of methionine meta-
bolism for the maintenance of histone methylation and the con-
sequences for expression of oncogenic programs. Thus it is
tempting to speculate that some of the anti-tumor effects of
targeting one-carbon metabolism may occur through changes
in cancer epigenetics, and further studies could more deeply
elaborate these mechanisms.
EXPERIMENTAL PROCEDURES
Methionine Restriction in Cell Culture
Briefly, CRC cells were grown in RPMI supplemented with 10% fetal bovine
serum and 100 U/mL penicillin and streptomycin. For methionine restriction
experiments, media was changed to either conditional media lacking
methionine (MET) or media with methionine (+MET) for indicated times.
Detailed protocol and media recipes are provided in the Supplemental
Information.Cell MMouse Feeding and Tissue and Plasma Analysis
Mouse feeding and sample collection were performed as previously
described (Ables et al., 2012). Briefly, C57BL/6J mice were randomly as-
signed to either an isocaloric, 0.85% (w/w) methionine (control) or a 0.12%
(w/w) methionine (MR) diet and sacrificed after 12 weeks. All animal proce-
dures were approved by the Institutional Animal Care and Use Committee
of the Orentreich Foundation for the Advancement of Science (Permit
Number 0511MB). Detailed methods are described in the Supplemental
Information.
Metabolite Extraction and LC-HRMS Analysis
The procedures for cultured cells, serum, and tissues were described in previ-
ous studies (Liu et al., 2014a, 2014b). Additional methods for liquid chromatog-
raphy mass spectrometry (LC-MS) analysis are provided in the Supplemental
Information.
RNA-Seq
Total RNA from +MET and MET conditions was polyA selected, and libraries
were prepared according to a standard protocol provided by Illumina and
sequenced on the Illumina HiSEQ 2500 Rapid Run sequencer.
ChIP-Seq
Hct116 cells from +MET and MET conditions were crosslinked, and each
immunoprecipitation was performed as previously described (Ercan et al.,
2007; Landt et al., 2012) using 1.53 106 cells. Libraries weremade and pooled
according to Illumina instructions, then sequenced on an Illumina HiSEQ 2500
Rapid Run sequencer.
Human Studies
Serum samples, 4-day diet records, and body composition results (via DEXA
scan) on 24 de-identified healthy older adults were provided by Marcas Bam-
man at the University of Alabama at Birmingham (UAB). As part of the UAB
Institutional Review Board-approved parent project, all 24 subjects agreed
to have their samples and data used for future research.
Statistical Analysis
Error bars represent SEM. Significance figures are from Student’s t tests un-
less otherwise noted.
Computational Modeling
In brief, a set of 12 predictor variables were obtained after a variable
selection process that incorporates methionine correlations, a dimensional
reduction of the DEXA data using principal-components analysis, and a
collinearity assessment using the variance inflation factor. We next gener-
ated a mixed-effects linear model including the set of predictor variables,
a random-effect term, and noise. Model selection was carried out using
exhaustive sampling and optimization of the Akaike information criterion.
Variance contributions for each variable and random effect were summed
to define the total contribution of variance for each variable and unexplained
factor. The full details of the modeling are contained in the Supplemental
Information.
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